Healthcare Analytical Testing Services Market 2022 Analysis and Forecast To 2026
                     MarketsandMarkets 
Presents
Healthcare Analytical Testing Services Market worth $9.8 billion by 
2026
https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-
market-108923833.html
The report "Healthcare Analytical Testing Services Market by Type (Method Development & 
Validation, Cell-based Assays, Stability Testing, Heavy Metal Testing, Thermal Analysis, Cleaning 
Validation), End User (Pharmaceutical Companies, CROs) - Global Forecast to 2026" The 
healthcare analytical testing services market is projected to reach USD 9.8  billion by 2026 from 
USD 5.6 billion in 2021, at a CAGR of 11.9%. 
Growth in the market is driven by analytical testing of biologics and biosimilars, increasing 
outsourcing of analytical testing by pharmaceutical companies, and rising number of clinical 
trials. In this report the global healthcare analytical testing services market is segmented by 
type, end user, and region.
The healthcare analytical testing services market exhibited a  dip in the year-on-year growth rate 
for the first half of 2020 since the COVID-19 outbreak resulted in decreased drug production in 
many countries. This impacted many segments of the analytical testing market, such as raw 
material testing and physical characterization services. However, there has been a solid recovery 
in the market from Q3 2020, fueled by growth in the pharmaceutical industry in response to the 
COVID-19 pandemic. In this report, the global healthcare analytical testing services market is 
segmented by type, end user, and region.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownload
Objectives of the Study:
• To define, describe, analyze, and forecast the size of the healthcare analytical testing services 
market on the basis of type, end-user, and region.
• To provide detailed information on the major factors influencing market growth (drivers, 
restraints, opportunities, and industry-specific challenges)
• To strategically analyze the micromarkets1 with respect to individual growth trends, 
prospects, and contributions to the overall market
• To forecast the size of the market segments with respect to North America, Europe, Asia 
Pacific, Latin America, and Middle East & Africa.
• To profile key players and comprehensively analyze their service portfolios, market positions, 
and core competencies.
• To track and analyze competitive developments such as service launches, expansions, 
partnerships, agreements, collaborations, acquisitions and other developments in the 
market.
• To benchmark players within the healthcare analytical testing services market using the 
Competitive Leadership Mapping framework which analyzes market players on various 
parameters within the broad categories of business and service strategy.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalyst
The research report categorizes the market into the following 
segments and subsegments:
By Type
Bioanalytical Testing Services
Physical Characterization Services
Method Development & Validation Testing Services
Raw Material Testing Services
Batch-Release Testing Services
Stability Testing
Microbial Testing Services
Environmental Monitoring Services
By End User
Pharmaceutical & Biopharmaceutical Companies
Medical Device Companies
Clinical Research Organizations
Prominent players in the healthcare analytical testing services market include Eurofins 
Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. 
(Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), PPD, Inc. 
(US), Element Materials Technology (UK), Thermo Fisher Scientific (US), Pace Analytical 
Services, LLC. (US), Intertek Group LLC. (UK), Merck KGaA (Germany), Danaher 
Corporation (US), Source BioScience (UK), Almac Group (UK), ICON plc (Ireland), 
Frontage Laboratories, Inc. (US), STERIS plc (US), Sartorius AG (Germany), ALS Life 
Science (US), Syneos Health (US), Medpace Holdings, Inc. (US), Cinven (LGC Limited) 
(UK), Anacura (Belgium), Impact Analytical (US), & CD BioSciences (US).
Company Insights
Eurofins Scientific (US) is a leading player in the healthcare analytical testing services market and 
accounted for the largest share of the market in 2020. The company’s services in the healthcare 
analytical testing services market quality control, manufacturing/process validation, analytical 
development, microbiology, and other testing for pharmaceutical and biopharmaceutical 
industries.  In August 2021, Eurofins Scientific acquired a CRO, bioskin GmbH (Germany), to 
strengthen Eurofins’ leadership position. Similarly, in November 2020, the company acquired 
Taiyo Techno Research (Japan) to strengthen its market leadership in Japan.
LabCorp (US) is one of the prominent players in the healthcare analytical testing services market. 
The company operates through two key segments—LabCorp Diagnostics (Dx) and LabCorp Drug 
Development (DD). Dx is an independent clinical laboratory business, while the DD segment 
provides end-to-end drug development and medical device & companion diagnostic 
development solutions from early-stage research to clinical development and commercial 
market access. The company provides healthcare analytical testing service offerings through its 
LabCorp Drug Development operating segment. In June 2019, LabCorp’s Covance Drug 
Development business completed the acquisition of Envigo, a leading provider of research 
models and services to enhance research support for biopharmaceutical & life sciences 
industries.
About MarketsandMarkets
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche 
opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. 
Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 
companies as clients. Almost 75,000 top officers across eight industries worldwide 
approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high 
growth markets following the "Growth Engagement Model – GEM". The GEM aims at 
proactive collaboration with the clients to identify new opportunities, identify most 
important customers, write "Attack, avoid and defend" strategies, identify sources of 
incremental revenues for both the company and its competitors. MarketsandMarkets™ 
now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, 
emerging companies, innovators, strategic players) annually in high growth emerging 
segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies 
this year for their revenue planning and help them take their innovations/disruptions 
early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, 
"RT" connects over 200,000 markets and entire value chains for deeper understanding 
of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road, Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
[email protected]
Press release:
https://www.marketsandmarkets.com/PressReleases/healthcare-anal
ytical-testing-services.asp
Research insights:
https://www.marketsandmarkets.com/ResearchInsight/healthcare-an
alytical-testing-services-market.asp